Terminal Complement Deficiency — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — C5 deficiency
Recurrent meningococcal infections are strongly associated with deficiency of terminal complement components (C5–C9) that form the membrane attack complex (MAC). C5 deficiency is the most commonly tested. Absent CH50 confirms a complement pathway defect. All patients with recurrent Neisseria infections should be tested. They should receive meningococcal vaccination (ACWY + B) and may require antibiotic prophylaxis. Eculizumab (anti-C5) therapy also creates a similar susceptibility.
Reference: eTG – 2025 – Immunology; ASCIA – 2024 – Complement Deficiency Guidelines